E-mail us: service@prospectnews.com Or call: 212 374 2800
Bank Loans - CLOs - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products
 
Published on 2/28/2013 in the Prospect News PIPE Daily.

Tesaro prices $84.96 million public offering of common stock at $18.00

4.72 million common shares sold by Citigroup, Morgan Stanley in deal

By Devika Patel

Knoxville, Tenn., Feb. 28 - Tesaro, Inc. said it priced an $84.96 million public sale of stock with a $12.74 million greenshoe.

The company will sell 4.72 million common shares at $18.00 per share. The price per share is a 0.99% discount to the Feb. 27 closing share price of $18.18.

Citigroup and Morgan Stanley are the joint bookrunning managers.

Settlement is expected March 5.

Tesaro is an oncology-focused biopharmaceutical company based in Waltham, Mass.

Issuer:Tesaro, Inc.
Issue:Common stock
Amount:$84.96 million
Greenshoe:$12,744,000
Shares:4.72 million
Price:$18.00
Warrants:No
Bookrunners:Citigroup and Morgan Stanley
Co-managers:Leerink Swann, Deutsche Bank Securities, BMO Capital Markets and Baird
Pricing date:Feb. 28
Settlement date:March 5
Stock symbol:Nasdaq: TSRO
Stock price:$18.18 at close Feb. 27
Market capitalization:$522.33 million

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.